510(k) K061165
K061165 is an FDA 510(k) premarket notification submitted by Sweden Diagnostics (Us), Inc. for the device "ELIA CCP, MODEL 14-5515-01; ELIA CCP CONTROL, MODEL 83-1009-01". The FDA issued a decision of Substantially Equivalent on August 3, 2006. The device falls under product code NHX (Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)), a Class II device regulated under 21 CFR 866.5775.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 3, 2006
- Date Received
- April 26, 2006
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)
- Device Class
- Class II
- Regulation Number
- 866.5775
- Review Panel
- IM
- Submission Type
The device is used for the detection of anti-cyclic citrullinated peptide (CCP) antibodies in human serum or plasma as an aid in the diagnosis of rheumatoid arthritis.